Navigation Links
Overactive Blood Platelets May Play Role in Lupus
Date:9/1/2010

By Melissa Lee Phillips
HealthDay Reporter

WEDNESDAY, Sept. 1 (HealthDay News) -- Overactive blood platelets could trigger inflammation in those with lupus, but the anti-clotting drug Plavix might ease the painful symptoms of this autoimmune disease, a new study suggests.

Platelets, which are the colorless, disc-shaped blood cells that are key to clotting, are suspected to be involved in lupus, explained senior study author Dr. Patrick Blanco, of the University of Bordeaux in France, but "their precise role was poorly understood until now."

Systemic lupus erythematosus (SLE) is a chronic disease thought to develop when the body's own antibodies start attacking organs. Sufferers experience recurring pain and inflammation in many parts of their body. Some common symptoms include joint pain or swelling, muscle pain, fever with no known cause, and red rashes, often on the face, according to the U.S. National Library of Medicine.

The exact cause of lupus is unknown, although research suggests that both environmental and genetic factors contribute to the disease.

Presently, there is no cure for the disease, which can be fatal. Current treatments include steroids and chemotherapy-like drugs, but they have assorted toxic effects, the study authors noted.

Blanco and his colleagues theorized that blood platelets might be involved in lupus because of their known role in the inflammatory process. To test this theory, they examined the blood of 37 lupus patients and compared their platelets to those from individuals without the disease.

They found that platelets in people with lupus were abnormally "activated" -- they expressed too much of a protein that's involved in blood clotting. These activated platelets, in turn, triggered production of proteins called interferons, which are known to promote inflammation.

The authors found that destroying blood platelets in mice prone to lupus relieved symptoms of the disease. They also treated these mice with the antiplatelet drug clopidogrel (Plavix), which is commonly used in humans to treat heart disease and stroke. The mice showed reduced lupus symptoms and they lived three months longer than mice that weren't treated with the drug.

The results suggest that it's possible that such anti-clotting drugs could improve outcomes in patients with lupus, said Blanco. He and his colleagues are currently designing clinical trials in humans to test this possibility.

The study finding was published in the Sept. 1 issue of Science Translational Medicine.

More information

There's more on lupus at the Lupus Foundation of America.

SOURCES: Patrick Blanco, M.D., Ph.D., University of Bordeaux, France; Sept. 1, 2010, Science Translational Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Overactive Thyroid Linked to Stroke in Young Adults
2. McMaster study contradicts reports of problems with blood-thinner
3. Even modest weight gain can harm blood vessels, Mayo researchers find
4. Novel role: EZH2 boosts creation of ovarian cancer blood vessels
5. Scientists map epigenetic changes during blood cell differentiation
6. Selected cells from blood or bone marrow may provide a route to healing blood vessels
7. Just a Little Belly Fat Can Damage Blood Vessels
8. Caltech biologists discover microRNAs that control function of blood stem cells
9. MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
10. Experts Support FDA Panels Backing of New Blood Thinner
11. Implantable Sensor Measures Blood Sugar Levels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Overactive Blood Platelets May Play Role in Lupus
(Date:7/25/2017)... Beach, Florida (PRWEB) , ... July 25, 2017 ... ... employee, Jennifer Haller, to the sales department joining as Regional Account Manager for ... relationships with contracted customers in the liquidation of their obsolete medical assets. , ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... and finance management services to communities across North Carolina, is launching a charity ... to raise community support for the ongoing fight against bladder cancer. , The ...
(Date:7/25/2017)... ... 25, 2017 , ... Dr. Donna Bergman, professor of education ... published an article in the medical science journal Physical Medicine and Rehabilitation titled ... and the research that helped produce it, were written and conducted in collaboration ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... as medical director. Dr. Negrette has more than a decade of experience in ... worked closely with individuals fighting addictions, eating disorders, psychotic and manic conditions, as ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... for its Product Innovation in the prestigious CEO World Awards®. The coveted annual ... new products and services, CEO case studies, corporate social responsibility, and milestones from ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... 2017 Did you know that PhRMA member companies invested ... combined spending on brand medicines, generics and the supply chain account ... for just half of this (7 percent)? Or that ... world,s venture capital investments in high-growth biopharmaceutical startups? ... The ...
(Date:7/17/2017)... 17, 2017  MedX Holdings, Inc., the manufacturer and ... and rehabilitation equipment, today announced the national roll out ... considered the gold standard for the treatment of low ... strengthening equipment. How ... physician or practice who prescribe the MedX Home Back ...
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
Breaking Medicine Technology: